- Home
- VALN vs RERE Comparison
VALN vs RERE Comparison
Compare VALN & RERE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALN
- RERE
- Stock Information
- Founded
- VALN 2012
- RERE 2011
- Country
- VALN France
- RERE China
- Employees
- VALN N/A
- RERE N/A
- Industry
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- RERE Other Specialty Stores
- Sector
- VALN Health Care
- RERE Consumer Discretionary
- Exchange
- VALN Nasdaq
- RERE Nasdaq
- Market Cap
- VALN 777.9M
- RERE 932.6M
- IPO Year
- VALN 2021
- RERE 2021
- Fundamental
- Price
- VALN $10.44
- RERE $4.11
- Analyst Decision
- VALN Strong Buy
- RERE
- Analyst Count
- VALN 4
- RERE 0
- Target Price
- VALN $15.75
- RERE N/A
- AVG Volume (30 Days)
- VALN 77.5K
- RERE 1.6M
- Earning Date
- VALN 11-06-2025
- RERE 11-19-2025
- Dividend Yield
- VALN N/A
- RERE N/A
- EPS Growth
- VALN N/A
- RERE N/A
- EPS
- VALN N/A
- RERE 0.12
- Revenue
- VALN $230,566,060.00
- RERE $2,588,775,650.00
- Revenue This Year
- VALN $15.69
- RERE $30.66
- Revenue Next Year
- VALN $22.15
- RERE $25.12
- P/E Ratio
- VALN N/A
- RERE $32.33
- Revenue Growth
- VALN 25.47
- RERE 27.39
- 52 Week Low
- VALN $3.62
- RERE $2.00
- 52 Week High
- VALN $12.25
- RERE $4.93
- Technical
- Relative Strength Index (RSI)
- VALN 51.09
- RERE 44.80
- Support Level
- VALN $10.08
- RERE $3.78
- Resistance Level
- VALN $11.35
- RERE $4.16
- Average True Range (ATR)
- VALN 0.43
- RERE 0.24
- MACD
- VALN -0.13
- RERE -0.07
- Stochastic Oscillator
- VALN 29.25
- RERE 34.36
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
About RERE ATRenew Inc.
ATRenew Inc is a pre-owned consumer electronics transactions and services platform in China. The majority of its revenue is derived from online product sales of phones and other consumer electronics goods through its platform. The Company's principal operations and geographic markets are in the People's Republic of China.